N-linked glycan compounds
US-9221898-B2 · Dec 29, 2015 · US
US10968285B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10968285-B2 |
| Application number | US-201816000370-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 5, 2018 |
| Priority date | Aug 18, 2011 |
| Publication date | Apr 6, 2021 |
| Grant date | Apr 6, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention discloses a matrix comprising a modified polysaccharide consisting of repeating disaccharide units whereby in at least 11% of the disaccharide units one primary alcohol group is oxidized into a carboxylic acid group.
Opening claim text (preview).
The invention claimed is: 1. A plastic surgery implant consisting essentially of a matrix comprising: at least one modified polysaccharide consisting of repeating disaccharide units, wherein the primary alcohol group is oxidized to a carboxylic acid group in at least 11% of the disaccharide units, wherein the matrix further comprises at least one unmodified polysaccharide, wherein the weight ratio of the modified polysaccharide to unmodified polysaccharide in the matrix is greater than 10 wt % of a modified polysaccharide, and wherein the shear modulus G′ of the matrix is in the range of from 10 Pa to 10 7 Pa. 2. The plastic surgery implant of claim 1 , wherein the at least one modified polysaccharide is selected form the group consisting of a member of the carrageenan family, hyaluronic acid, heparin sulfate, dermatan sulfate, chondroitin sulfate, alginate, chitosan, pullulan, and agarose. 3. The plastic surgery implant of claim 1 , wherein the at least one modified polysaccharide is agarose. 4. The plastic surgery implant of claim 1 , wherein the at least one unmodified polysaccharide is selected from the group consisting of a member of the carrageenan family, hyaluronic acid, heparin sulfate, dermatan sulfate, chondroitin sulfate, alginate, chitosan, pullulan, and agarose. 5. The plastic surgery implant of claim 1 , wherein the at least one unmodified polysaccharide is agarose. 6. The plastic surgery implant of claim 1 , wherein the shear modulus G′ of the matrix is in the range of from 10 Pa to 100 kPa. 7. The plastic surgery implant of claim 1 , wherein one primary alcohol group is oxidized to a carboxylic acid group in at least 20-99% of the disaccharide units. 8. A method for reconstructive and cosmetic surgery, the method comprising implanting in plastic surgery a plastic surgery implant according to claim 1 . 9. A plastic surgery implant consisting essentially of a matrix comprising: at least one modified agarose consisting of repeating disaccharide units, wherein one primary alcohol group is oxidized to a carboxylic acid group in at least 11% of the disaccharide units, wherein the matrix further comprises at least one unmodified agarose, wherein the weight ratio of the modified polysaccharide to unmodified polysaccharide in the matrix is greater than 10 wt % of a modified polysaccharide, and wherein the shear modulus G′ of the matrix is in the range of from 10 Pa to 10 7 Pa.
Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof (cellulose D21; {microbiological processes C12P}) · CPC title
Cosmetics or similar toiletry preparations for specific uses not provided for in other groups of this subclass · CPC title
Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof · CPC title
Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof · CPC title
Agar; Agarose, i.e. D-galactose, 3,6-anhydro-D-galactose, methylated, sulfated, e.g. from the red algae Gelidium and Gracilaria; Agaropectin; Derivatives thereof, e.g. Sepharose, i.e. crosslinked agarose · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.